MedTrace Logo

Impact of Continuing Medical Education (CME) Insulin Program

NCT00824603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2015-12-02

No results posted yet for this study

Summary

The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement of patients in the decision making as to whether to initiate insulin therapy.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Margaret Powers, PhD · International Diabetes Center at Park Nicollet

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00824603 on ClinicalTrials.gov